[Sleep attacks and pergolide mesylate].
García Ruiz
P J
PJ
Hernández
J
J
Cantarero
S
S
Fanjul
S
S
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced* / Q000503:physiopathology; D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy; D010479:Pergolide / Q000009:adverse effects* / Q000627:therapeutic use
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D010479:Pergolide